News

Dr Wolf will continue to represent Conelis e.V. as a chair

Dr Wolf will continue to represent Conelis e.V. as the acting chair of the Executive Board.

[...]

21 Oct 2022  |  News  |  Press Releases

ECTRIMS 2022 Amsterdam

Dr Wolf will attend the congress of the European Committee on Treatment and Research in Multiple Sclerosis from 26-28 October 2022 in Amsterdam in person.

[...]

18 Oct 2022  |  News  |  Events

How to use biosimilars and generic NBCDs as MS DMTs?

just published and co-authored by Dr Wolf:

Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendation.

[...]

24 Aug 2022  |  News  |  New Publications

Phase II for a 2nd-generation DHDOH inhibitor

just published and co-authored by Dr Wolf:

A double-blind, randomized, placebo-controlled phase 2 trial evaluating the selective dihydroorotate dehydrogenase inhibitor vidofludimus calcium in relapsing-remitting multiple sclerosis.

[...]

14 Jun 2022  |  News  |  New Publications

A Continued Role for Glatiramer Acetate?

just published and co-authored by Dr Wolf:

Treatment Challenges in Multiple Sclerosis – A Continued Role for Glatiramer Acetate?

[...]

15 Apr 2022  |  News  |  New Publications

Dr Wolf re-elected chair of Conelis

Dr Wolf has been re-elected chair of the Executive Board of Conelis e.V. during the association's General Assembly on 30 October 2020.

[...]

30 Oct 2020  |  News  |  Press Releases

IMSCOGS 2019 Amsterdam

Dr Wolf attends the 2019 annual meeting of the International Multiple Sclerosis Cognition Society (IMSCOGS) in Amsterdam's Compagnietheater on 6 and 7 June.

[...]

6 Jun 2019  |  News  |  Events

2nd drug approved with Lycalis' support

Yesterday, the US FDA approved Novartis' drug Mayzent® (siponimod) for treatment of relapsing forms of multiple sclerosis (RMS) including clinically isolated syndrome (CIS), relapsing remitting disease, and active secondary progressive disease, in adults. Lycalis has accompanied the development of siponimod since 2009.

[...]

27 Mar 2019  |  News  |  Press Releases

AAN 2019 Philadelphia

Dr Wolf will attend the Annual Meeting of the American Academy of Neurology from 4-10 May 2019 in Philadelphia.

[...]

13 Mar 2019  |  News  |  Events

Dr Wolf elected chair of Conelis

Dr Wolf has been elected chair of the Executive Board of Conelis e.V. during the association's General Assembly on 12 October 2018.

[...]

12 Oct 2018  |  News  |  Press Releases

Dr Wolf re-elected treasurer of Conelis e.V.

Dr Wolf has been re-elected treasurer and member of the Executive Board of Conelis e.V. during the association's General Assembly on 7 October 2016.

[...]

7 Oct 2016  |  News  |  Press Releases

ECTRIMS 2016 London

Dr Wolf attends the congress of the European Committee on Treatment and Research in Multiple Sclerosis from 14-17 September 2016 at the Excel Convention Centre in London.

[...]

14 Sep 2016  |  News  |  Events

AAN 2016 Vancouver

Dr Wolf will attend the Annual Meeting of the American Academy of Neurology from 15-21 April 2016 in Vancouver.

[...]

12 Apr 2016  |  News  |  Events

Landmark clinical equivalence study in MS

just published and co-authored by Dr Wolf:

Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis. A Randomized Clinical Trial.

[...]

12 Oct 2015  |  News  |  New Publications

ECTRIMS 2015 Barcelona

Dr Wolf attends the Congress of the European Committee on Treatment and Research in Multiple Sclerosis from 6-10 October 2015 at the Centre de Convencions Internacional in Barcelona.

[...]

5 Oct 2015  |  News  |  Events

Win a Day with Experts!

Berlin, Bremen (Germany) | 12 May 2015

SACURA, Conelis and GCP-Services International started a campaign to support biotech companies on the International Day of Clinical Trials

[...]

12 May 2015  |  News  |  Press Releases

AAN 2015 Washington

Dr Wolf's poster presentation at AAN:

Selmaj K, Barkhof F, Wolf C, Belova A, Oberyé JJL, van den Tweel ERW, Mulder R, Koper NP, Voortman G, Cohen JA. Similar Local Tolerability Profiles Following Double-Blind Treatment With Generic or Branded Glatiramer Acetate in Multiple Sclerosis (full text).

[...]

21 Apr 2015  |  News  |  Events

EMSP Briefing and Networking Event

On invitation of the Executive Committee of the advocacy organisation  European Multiple Sclerosis Platform (EMSP), Dr Wolf attended a Briefing and Networking Event in downtown Brussels.

[...]

2 Mar 2015  |  News  |  Events

Joint ECTRIMS/ACTRIMS 2014 Boston

Dr Wolf attends the Joint Congress of the European and American Committee on Treatment and Research in Multiple Sclerosis from 10-13 October 2014 at the John B. Hynes Veterans Memorial Convention Center in Boston.

[...]

10 Sep 2014  |  News  |  Events

Joint Congress of European Neurology

Dr Wolf attended the Joint Congress of European Neurology from 31-May to 3-June-2014 in Istanbul.

[...]

3 Jun 2014  |  News  |  Events

Step Award

The STEP Award is a competition designed to recognize innovative growth companies in Germany, Austria and Switzerland.

[...]

24 May 2014  |  News  |  Miscellaneous

Win a Day with Experts!

Berlin, Bremen (Germany) | 21 May 2014

The German organisations Sacura GmbH, Conelis e.V. and GCP-Services International Ltd. & Co. KG launched a campaign to support young, small biotech/biopharmaceutical companies engaged in the development of new medicinal products and therapies in human health care.

[...]

21 May 2014  |  News  |  Press Releases

Bionnale 2014 Berlin

Dr Wolf attended the Bionnale 2014 on 13-May-2014 in Berlin and represented Conelis e.V. during the Contact Forum.

[...]

13 May 2014  |  News  |  Events

Dr Wolf re-elected treasurer of Conelis e.V.

Dr Wolf has been re-elected treasurer and member of the Executive Board of Conelis e.V. during the association's General Assembly on 18 October 2013.

[...]

18 Oct 2013  |  News  |  Press Releases

EMA Workshop Multiple Sclerosis Guideline

Dr Wolf will attend the European Medicines Agency's Workshop on the clinical investigation of new medicines for the treatment of multiple sclerosis on 17 October 2013 in London.

[...]

17 Oct 2013  |  News  |  Events

Lecture on MS Drug Development (Düsseldorf)

Dr Christian Wolf was invited to lecture about MS drug development during the 15. Jahreskongress Klinische Pharmakologie on 10 October 2013 in Düsseldorf.

[...]

10 Oct 2013  |  News  |  Events

ECTRIMS 2013 Copenhagen

Dr Wolf will attend the Congress of the European Committee on Treatment and Research in Multiple Sclerosis from 1-5 October 2013 at the Bella Center in Copenhagen.

[...]

1 Oct 2013  |  News  |  Events

AAN 2013 San Diego

Dr Wolf will attend the Annual Meeting of the American Academy of Neurology from 16-23 March 2013 in San Diego.

[...]

16 Mar 2013  |  News  |  Events

Patient-volunteer studies in Multiple Sclerosis

just published and co-authored by Dr Wolf:

Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study.

[...]

5 Mar 2013  |  News  |  New Publications

BAPU 2012 Antwerpen

Dr Wolf attended the conference "Early Clinical Drug Development towards 2020" held by the Belgian Association of Phase I Units in Antwerp's Astrid Hotel on 9 November 2012.

[...]

9 Nov 2012  |  News  |  Events

ECTRIMS 2012 Lyon

Dr Wolf will attend the Congress of the European Committee on Treatment and Research in Multiple Sclerosis from 10-13 October 2012 in Lyon.

[...]

9 Oct 2012  |  News  |  Events

Lycalis registered as an EU trademark

The name »Lycalis« has been approved as a Community trademark by the EU's Alicante-based »Office for Harmonization in the Internal Market« (OHIM) under the number 010711703.

[...]

13 Jul 2012  |  News  |  Press Releases

House of Lords

On invitation of Richmond Pharmacology Ltd, Dr Wolf attended a reception of Lord McColl of Dulwich in the House of Lords (London) held on behalf of the Clinical Contract Research Association.

[...]

10 Jul 2012  |  News  |  Miscellaneous

ENS 2012 Prague

Dr Wolf will attend the Annual Meeting of the European Neurological Society from 9-12 June 2012 in Prague.

[...]

2 Jun 2012  |  News  |  Events

AAN 2012 New Orleans

Dr Wolf will attend the Annual Meeting of the American Academy of Neurology from 21-28 April 2012 in New Orleans.

[...]

2 Jun 2012  |  News  |  Events

Long-Term Disability in Multiple Sclerosis

just published and co-authored by Dr Wolf:

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.

[...]

11 Feb 2012  |  News  |  New Publications

Patient-volunteer studies in Multiple Sclerosis

just published and co-authored by Dr Wolf:

Benefits of a Single Versus Multicenter Approach in Early-Phase Patient Studies. A Case Study of Multiple Sclerosis Patients.

[...]

1 Nov 2011  |  News  |  New Publications

Dr Wolf elected treasurer of Conelis e.V.

Dr Wolf has been elected treasurer and member of the Executive Board of Conelis e.V. during the association's General Assembly on 23 September 2011.

[...]

1 Oct 2011  |  News  |  Press Releases

ECTRIMS 2011 Amsterdam

Dr Wolf will attend the Joint Triennial Congress of the European and Americas Committees on Treatment and Research in Multiple Sclerosis from 19-22 October 2011 in Amsterdam.

[...]

17 Sep 2011  |  News  |  Events

Workshop FIM and Phase II (Berlin)

Dr Christian Wolf will speak at the workshop "Pharmaentwicklung: Erstanwendung am Menschen und Phase II" on 28 October 2011 in Berlin-Buch.

[...]

1 Aug 2011  |  News  |  Events

Drug-Related PML: Transatlantic Workshop

Dr Wolf will attend the Transatlantic workshop: drug-related progressive multifocal leukoencephalopathy from 25-26 July 2011 in London.

[...]

21 Jul 2011  |  News  |  Events

CSF and Blood Biobanking

just published and co-authored by Dr Wolf:

Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.

[...]

21 Jul 2011  |  News  |  New Publications